Abstract:BACKGROUND:Mucinous breast carcinoma (MC) is a special type of breast cancer that presents with a large amount of extracellular mucin. MC comprises approximately 4% of all invasive breast cancers. This type of tumor has a better prognosis and higher incidence in peri- and post-menopausal patients. Pathologically, there are two main subtypes of MC: pure and mixed. In this study, we describe 10 years of experience with MC at the Zhejiang Cancer Hospital in China, specifically, clinical data, histological findings and immunohistochemical features. METHODS:We identified MC patients who were diagnosed as operable and completed clinical treatment from January 2001 to January 2011. The clinicopathological data included the age at diagnosis, tumor size, TNM stage, presence and number of lymph node (LN) metastases, estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor-2 (HER2) status and p53 expression. If the tumor was defined as mixed mucinous carcinoma (MMC), IHC was performed on a non-mucinous part, such as invasive ductal and lobular cancer. We evaluated the clinical characteristics of all MC patients using chi-square, one-way ANOVA and LSD tests. We also studied the correlations between all of the clinical parameters and LN metastasis in a binary logistic regression analysis. We used ten consecutive years of data that were collected at Zhejiang Cancer Hospital. RESULTS:We identified 48 cases of pure mucinous carcinoma (PMC) and 77 cases of MMC. The 48 PMC cases consisted of 38 PMC-A and 10 PMC-B subtypes. The MMCs were divided into two groups, those with partial mixed mucinous breast carcinoma (pMMC, 58 cases) and those with main mixed mucinous breast carcinoma (mMMC, 19 cases). pMMC was defined by tumors with less than 50% mucinous components, while mMMC was defined by tumors where the mucinous component accounted for 50% to 90% of the tumor. No significant differences in the clinicopathological characteristics were noted between the patients with PMC-A and those with PMC-B. The tumor size was larger in the mMMC than PMC cases (44.84 mm vs. 30.06 mm, p = 0.021). The number of positive LN metastases was greater in pMMC than PMC patients (p = 0.024). The clinical stages were significantly different among the three groups, with the pMMC group having more stage III-IV patients than the other two groups (p = 0.005). The incidence of LN metastasis was also higher in the pMMC cases (pMMC vs. mMMC and PMC, 50% vs. 31.58% and 18.75%, p = 0.003). The PMC patients had much lower p53 expression than the other two groups (PMC vs. pMMC and mMMC, 27.08% vs. 55.17% and 57.89%, p = 0.007). The tumor size (>30mm), p53 expression and less proportion of the mucinous component are associated with risk of LN metastasis. CONCLUSION:Based on the results of this study, we conclude that the tumor size, status of LN metastasis, clinical stage, and p53 mutation rate may differ between MMC and PMC patients. The tumor size (>30mm), p53 mutation and less proportion of the mucinous component should be considered risk factors of LN metastasis in MC patients.

Clonal and Genetic Relationship Between Individual Components of Mucoepidermoid Carcinoma: X-chromosome Inactivation Assay and Microsatellite Analysis.

Clinicopathological Practice in the Differential Diagnosis of Mucoepidermoid Carcinoma from Neoplasms with Mucinous Component

A Clinicopathological and Molecular Analysis of Cervical Carcinomas with Basaloid Features

The clinical outcome, pathologic spectrum, and genomic landscape for 454 cases of salivary mucoepidermoid carcinoma

Identification Of Differentially Expressed Genes Between Mucinous Adenocarcinoma And Other Adenocarcinoma Of Colorectal Cancer Using Bioinformatics Analysis

Two Subtypes of Mucinous Colorectal Carcinoma Characterized by Laser Scanning Cytometry and Comparative Genomic Hybridization

Clinicopathological Characteristics of Mucinous Breast Cancer: A Retrospective Analysis of a 10-Year Study.

Loss of OPCML Expression and the Correlation with CpG Island Methylation and LOH in Ovarian Serous Carcinoma.

Extended Immunologic and Genetic Lineage of Mammary Analogue Secretory Carcinoma of Salivary Glands

Mucin expression, p53 overexpression, and peritumoral lymphocytic infiltration of advanced colorectal carcinoma with mucus component: is mucinous carcinoma a distinct histological entity?

Clonality of squamous intraepithelial lesion of cervix

Clinical Characteristics and Outcome of Mucinous Breast Cancer: A Retrospective Analysis of 10-Year Study.

Expanding the cytological and architectural spectrum of mucoepidermoid carcinoma: The key to solving diagnostic problems in morphological variants

Clinicopathologic characteristics and molecular phenotype of breast mucinous carcinoma and its clinical significance

Increased Expression of Muc-1 Has Close Relation with Patient Survivor in High-Grade Salivary Gland Mucoepidermoid Carcinoma

Clonality analysis of intraductal proliferative lesions in the mammary gland

Screening and bioinformatics analysis of mRNA, long non-coding RNA and circular RNA expression profiles in mucoepidermoid carcinoma of salivary gland.

Gene expression and clonality analysis of the androgen receptor and phosphoglycerate kinase genes in polygonal cells and cuboidal cells in so-called pulmonary sclerosing hemangioma

Pulmonary Mucoepidermoid Carcinoma: Clinicopathological Characteristics of 20 Cases and a Literature Review

Identification of Ampullary Carcinoma Mixed Subtype Using a Panel of Six Antibodies and Its Clinical Significance.

Mucinous Carcinoma with Micropapillary Features is Morphologically, Clinically and Genetically Distinct from Pure Mucinous Carcinoma of Breast.